Kyoto, Japan

Tatsuo Suminokura


Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1976-1977

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Tatsuo Suminokura: Pioneering Anti-Inflammatory Agents

Introduction

Tatsuo Suminokura is a renowned inventor based in Kyoto, Japan, with a notable contribution to the field of pharmaceutical compositions. With a total of two patents to his name, Suminokura has made significant strides in developing anti-inflammatory agents that showcase his innovative spirit and expertise in chemistry.

Latest Patents

Suminokura's latest patents include "Steryl-β-D-glucoside esters and method of preparation," which details the creation of steryl-6-O-palmitoyl-β-D-glucosides. These compounds function as effective anti-inflammatory agents, with β-sitosteryl-6-O-palmitoyl-β-D-glucoside standing out as a primary example. The method involves a reaction between a steryl-6-O-sulfonyl-β-D-glucoside and an alkali metal salt of palmitic acid. Another significant patent is the "Steryl-β-D-glucoside ester pharmaceutical compositions and method," which elaborates on steryl-6-O-palmitoyl and -2,3,4,6-O-tetrapalmitoyl-β-D-glucosides as anti-inflammatory agents. This involves the reaction of a steryl-β-D-glucoside with a lower alkyl ester of palmitic acid, aided by a basic catalyst.

Career Highlights

Tatsuo Suminokura has established himself as an integral member of Nippon Shinyaku Company, Ltd., where he continues to push the boundaries of pharmaceutical research. His work has not only contributed to the advancement of anti-inflammatory treatments but has also enhanced the understanding of glucoside chemistry.

Collaborations

Throughout his career, Suminokura has collaborated with notable colleagues, including Hiromu Murai and Koji Kitaguchi. Their teamwork has fostered an innovative environment that has led to the successful development of new pharmaceutical applications and enhanced the efficacy of treatment options.

Conclusion

In conclusion, Tatsuo Suminokura's contributions to the field of pharmaceuticals through his innovative patents represent a meaningful step forward in anti-inflammatory therapies. His work at Nippon Shinyaku Company, Ltd. and collaboration with experienced professionals underscore the impact of teamwork in driving innovation and improving healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…